DiagnaMed Advances Hydrogen Energy Technology Innovation

TORONTO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed," "DMED," or the "Company") (CSE: DMED) (OTCQB: DGNMF), a leading provider of technology solutions for the hydrogen and life sciences industries, announces significant progress in the commercialization of its proprietary electromagnetic heating technology for hydrogen production.

Developed by Dr. Qingwang Yuan of the HOPE Group at Texas Tech University, this innovation enables the direct extraction of hydrogen from petroleum reservoirs and natural hydrogen fields, positioning DiagnaMed as a leader in sustainable energy solutions.

>> In Other News: Boomitra Secures Verra Registration for Its First Soil Carbon Project, Unlocking Carbon Finance for Ranchers in the Global South

Key Developments

Advanced Technology IntegrationDiagnaMed is integrating the newly licensed hydrogen generation technology from Texas Tech into its existing production systems. This enhancement is expected to increase efficiency, scalability, and cost-effectiveness in hydrogen production.

Strengthened Partnership with Québec Innovative Materials Corp.

The alliance between DMED and QIMC is being reinforced through initiatives that leverage DMED’s hydrogen technology and QIMC’s expertise in natural hydrogen. Together, they aim to expand renewable energy applications and accelerate the adoption of clean energy.

Commitment to Sustainability

DMED and QIMC remain dedicated to reducing greenhouse gas emissions and advancing the global shift to low-carbon energy. Their collaboration supports the development of economically viable, environmentally responsible energy solutions.

Advancing Business Development and Partnering DiscussionsDMED is focused on repurposing existing oil and gas infrastructure, including over 25,000 active oil and gas fields and 2-3 million abandoned wells in the United States, to accelerate the extraction of natural clean hydrogen. The company is in discussions with petroleum and natural hydrogen exploration companies.

Fabio Chianelli, Chairman and CEO of DiagnaMed, commented:“We are focused on commercializing our hydrogen production technology through strategic alliances with energy innovators, enabling cost-effective, carbon-neutral hydrogen production that aligns with global sustainability goals. We expect to engage with petroleum and natural hydrogen exploration companies to validate our business model and drive revenue at scale.”

About DiagnaMed

DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) delivers technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and AI-driven drug discovery and diagnostics. Visit DiagnaMed.com.